6336. Current Smoking and Reduced Mortality in Bacteremic Pneumococcal Pneumonia: A Population-Based Cohort Study.
作者: Jessica A Beatty.;Sumit R Majumdar.;Gregory J Tyrrell.;Thomas J Marrie.;Dean T Eurich.
来源: Chest. 2016年150卷3期652-60页
Previous studies suggest that smoking is independently associated with decreased mortality in patients with pneumonia. We hypothesized that this is a result of acquiring differential pneumococcal serotypes (ie, smokers with pneumococcal pneumonia are more likely to experience bacteremia, with low case fatality rate (CFR) serotypes). We tested this hypothesis in a population-based cohort of patients with bacteremic pneumococcal pneumonia (BPP).
6337. Making the GRADE: CHEST Updates Its Methodology.
作者: Rebecca L Diekemper.;Sheena Patel.;Stephen A Mette.;Joseph Ornelas.;Daniel R Ouellette.;Kenneth R Casey.
来源: Chest. 2018年153卷3期756-759页
The American College of Chest Physicians (CHEST) has been at the forefront of evidence-based clinical practice guideline development for more than 2 decades. In 2006, CHEST adopted a modified system of Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to support their rigorous guideline development methodology. The evolution of CHEST's Living Guidelines Model, as well as their collaborative efforts with other organizations, has necessitated improvements in their guideline development methodology. CHEST has made the decision to transition to the standard GRADE method for rating the certainty of evidence and grading recommendations in their evidence-based clinical practice guidelines, a deviation from the modified approach that was adopted in 2006. The standard GRADE approach will be used to grade recommendations in all CHEST guidelines, including updates to previously published guidelines. CHEST's adoption of a standard GRADE approach will ensure that its guideline development methodology is more consistent with that used by other organizations, will better align evidence synthesis methods, and will result in more explicit and easy to understand recommendations.
6338. Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study.
作者: Alain Tremblay.;Niloofar Taghizadeh.;Annette M McWilliams.;Paul MacEachern.;David R Stather.;Kam Soghrati.;Serge Puksa.;John R Goffin.;Kazuhiro Yasufuku.;Kayvan Amjadi.;Garth Nicholas.;Simon Martel.;Francis Laberge.;Michael Johnston.;Frances A Shepherd.;Diana N Ionescu.;Stefan Urbanski.;David Hwang.;Jean-Claude Cutz.;Harmanjatinder S Sekhon.;Christian Couture.;Zhaolin Xu.;Tom G Sutedja.;Sukhinder Atkar-Khattra.;Martin C Tammemagi.;Ming-Sound Tsao.;Stephen C Lam.; .
来源: Chest. 2016年150卷5期1015-1022页
Lung cancer screening with low-dose CT (LDCT) scan has been demonstrated to reduce lung cancer mortality. Preliminary reports suggested that up to 20% of lung cancers may be CT scan occult but detectable by autofluorescence bronchoscopy (AFB). We evaluated the prevalence of CT scan occult, invasive, and high-grade preinvasive lesions in high-risk participants undergoing screening for lung cancer.
6339. Impact of Acute Changes in CPAP Flow Route in Sleep Apnea Treatment.
作者: Rafaela G S Andrade.;Fernanda Madeiro.;Vivien S Piccin.;Henrique T Moriya.;Fabiola Schorr.;Priscila S Sardinha.;Marcelo G Gregório.;Pedro R Genta.;Geraldo Lorenzi-Filho.
来源: Chest. 2016年150卷6期1194-1201页
CPAP is the gold standard treatment for OSA and was conceived to be applied through a nasal interface. This study was designed to determine the acute effects of changing the nasal CPAP route to oronasal and oral in upper airway patency during sleep in patients with OSA. We hypothesized that the oronasal route may compromise CPAP's effectiveness in treating OSA.
6340. Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database.
作者: Thomas A Schwann.;Robert H Habib.;Rakesh M Suri.;J Matthew Brennan.;Xia He.;Vinod H Thourani.;Milo Engoren.;Gorav Ailawadi.;Brian R Englum.;Mark R Bonnell.;James S Gammie.
来源: Chest. 2016年150卷3期597-605页
Anticoagulation with warfarin following bioprosthetic mitral valve replacement (BMVR) is recommended by multiple practice guidelines. We assessed practice variability and patient characteristics associated with warfarin prescription following BMVR.
|